Literature DB >> 32171662

Meta-analysis Reveals Potential Influence of Oxidative Stress on the Airway Microbiomes of Cystic Fibrosis Patients.

Xing Shi1, Zhancheng Gao2, Qiang Lin3, Liping Zhao4, Qin Ma5, Yu Kang6, Jun Yu7.   

Abstract

The lethal chronic airway infection of the cystic fibrosis (CF) patients is predisposed by colonization of specific CF-philic pathogens or the CF microbiomes, but key processes and reasons of the microbiome settlement in the patients are yet to be fully understood, especially their survival and metabolic dynamics from normal to diseased status under treatment. Here, we report our meta-analysis results on CF airway microbiomes based on metabolic networks reconstructed from genome information at species level. The microbiomes of CF patients appear to engage much more redox-related activities than those of controls, and by constructing a large dataset of anti-oxidative stress (anti-OS) genes, our quantitative evaluation of the anti-OS capacity of each bacterial species in the CF microbiomes confirms strong conservation of the anti-OS responses within genera and also shows that the CF pathogens have significantly higher anti-OS capacity than commensals and other typical respiratory pathogens. In addition, the anti-OS capacity of a relevant species correlates with its relative fitness for the airways of CF patients over that for the airways of controls. Moreover, the total anti-OS capacity of the respiratory microbiome of CF patients is collectively higher than that of controls, which increases with disease progression, especially after episodes of acute exacerbation and antibiotic treatment. According to these results, we propose that the increased OS in the airways of CF patients may play an important role in reshaping airway microbiomes to a more resistant status that favors the pre-infection colonization of the CF pathogens for a higher anti-OS capacity.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Airway microbiome; Cystic fibrosis; Meta-analysis; ROS; Respiratory pathogens

Year:  2020        PMID: 32171662      PMCID: PMC7212475          DOI: 10.1016/j.gpb.2018.03.009

Source DB:  PubMed          Journal:  Genomics Proteomics Bioinformatics        ISSN: 1672-0229            Impact factor:   7.691


  74 in total

1.  Early inflammation in the airways of a cystic fibrosis foetus.

Authors:  Catherine Verhaeghe; Katty Delbecque; Laurence de Leval; Cecile Oury; Vincent Bours
Journal:  J Cyst Fibros       Date:  2007-01-12       Impact factor: 5.482

2.  The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis.

Authors:  Katherine B Frayman; David S Armstrong; Rosemary Carzino; Thomas W Ferkol; Keith Grimwood; Gregory A Storch; Shu Mei Teo; Kristine M Wylie; Sarath C Ranganathan
Journal:  Thorax       Date:  2017-03-09       Impact factor: 9.139

3.  Global responses of Aliivibrio salmonicida to hydrogen peroxide as revealed by microarray analysis.

Authors:  Hege L Pedersen; Erik Hjerde; Steinar M Paulsen; Hilde Hansen; Lotte Olsen; Sunniva K Thode; Marcos T Dos Santos; Ruth H Paulssen; Nils-Peder Willassen; Peik Haugen
Journal:  Mar Genomics       Date:  2010-10-30       Impact factor: 1.710

4.  Lactate in cystic fibrosis sputum.

Authors:  Tobias Bensel; Martin Stotz; Marianne Borneff-Lipp; Bettina Wollschläger; Andreas Wienke; Giovanni Taccetti; Silvia Campana; Keith C Meyer; Peter Ø Jensen; Ute Lechner; Martina Ulrich; Gerd Döring; Dieter Worlitzsch
Journal:  J Cyst Fibros       Date:  2010-10-13       Impact factor: 5.482

5.  CFTR directly mediates nucleotide-regulated glutathione flux.

Authors:  Ilana Kogan; Mohabir Ramjeesingh; Canhui Li; Jackie F Kidd; Yanchun Wang; Elaine M Leslie; Susan P C Cole; Christine E Bear
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

Review 6.  Cystic fibrosis: molecular biology and therapeutic implications.

Authors:  F S Collins
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

7.  The treatment-naive microbiome in new-onset Crohn's disease.

Authors:  Subra Kugathasan; Lee A Denson; Dirk Gevers; Yoshiki Vázquez-Baeza; Will Van Treuren; Boyu Ren; Emma Schwager; Dan Knights; Se Jin Song; Moran Yassour; Xochitl C Morgan; Aleksandar D Kostic; Chengwei Luo; Antonio González; Daniel McDonald; Yael Haberman; Thomas Walters; Susan Baker; Joel Rosh; Michael Stephens; Melvin Heyman; James Markowitz; Robert Baldassano; Anne Griffiths; Francisco Sylvester; David Mack; Sandra Kim; Wallace Crandall; Jeffrey Hyams; Curtis Huttenhower; Rob Knight; Ramnik J Xavier
Journal:  Cell Host Microbe       Date:  2014-03-12       Impact factor: 21.023

8.  Requirement of the Pseudomonas aeruginosa CbrA sensor kinase for full virulence in a murine acute lung infection model.

Authors:  Amy T Y Yeung; Laure Janot; Olga M Pena; Anke Neidig; Irena Kukavica-Ibrulj; Ashley Hilchie; Roger C Levesque; Joerg Overhage; Robert E W Hancock
Journal:  Infect Immun       Date:  2013-12-30       Impact factor: 3.441

9.  Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences.

Authors:  Morgan G I Langille; Jesse Zaneveld; J Gregory Caporaso; Daniel McDonald; Dan Knights; Joshua A Reyes; Jose C Clemente; Deron E Burkepile; Rebecca L Vega Thurber; Rob Knight; Robert G Beiko; Curtis Huttenhower
Journal:  Nat Biotechnol       Date:  2013-08-25       Impact factor: 54.908

10.  Demonstrating microbial co-occurrence pattern analyses within and between ecosystems.

Authors:  Ryan J Williams; Adina Howe; Kirsten S Hofmockel
Journal:  Front Microbiol       Date:  2014-07-18       Impact factor: 5.640

View more
  1 in total

Review 1.  The Microbiome in Cystic Fibrosis Pulmonary Disease.

Authors:  Alice Françoise; Geneviève Héry-Arnaud
Journal:  Genes (Basel)       Date:  2020-05-11       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.